News

Microsoft added a bunch of useful capabilities to Excel this month, including one that was highly requested by customers.
BioXcel's Phase 3 trial shows BXCL501 safely reduces agitation in schizophrenia patients, supporting plans for an FDA label ...
Exelixis’ (EXEL) lead drug, Cabometyx, a tyrosine kinase inhibitor (TKI), is one of the leading drugs for the treatment of ...